RGX-111 Gene Therapy in Patients With MPS I

Clinical trial NCT03580083 · SUSPENDED

Trial details

NCT number: NCT03580083
Sponsor: REGENXBIO Inc.
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mucopolysaccharidosis Type I (MPS I)Hurler Syndrome Hurler-Scheie Syndrome

Start date: 2019-04-03
Primary completion: 2027-07-07
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.